Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review - Top-Institutions - MDSpire

Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review

  • By

  • Mai A. Elkalla

  • Yousef G. Ali

  • Mohamed M. Ewais

  • Ahmed S. Taha

  • Mohab Sherif

  • December 22, 2025

  • 0 min

Share

Top Institutions in Rheumatology

Brief introduction explaining scope and methodology.

  • #1

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Pain Medicine

  • #2

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Neurogastroenterology

  • #3

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Neuroscience

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Pain Medicine

  • #5

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, MA

    Key Differentiators

    • Rheumatology
    • Gastroenterology
    • Neurogastroenterology

Original Source(s)

Efficacy and safety of interventions for Fibromyalgia syndrome comorbid with Irritable bowel syndrome: systematic review

  • by Mai A. Elkalla, Yousef G. Ali, Mohamed M. Ewais, Ahmed S. Taha, Mohab Sherif

  • December 22, 2025

Related Content

Is histamine intolerance a treatable subtype of fibromyalgia? evidence and clinical implications—narrative review

Understanding sensory abnormalities in fibromyalgia through autoantibodies

Editorial: Integrative Approaches to Fibromyalgia: Advancing Multidisciplinary Management Strategies